People
Find researchers
Who has published, run trials or held grants on a topic, and how to reach them through people they have worked with.
Ranked by expertise@1: every paper, trial or grant they worked on in scope counts, recent work counts more, and being first or last author or a trial’s principal investigator counts 1.5 times.
Researchers with CLDN18.2 work
238 researchers in CLDN18.2, best first; 201–225 shown.
- Hannah L. Williams
In CLDN18.2: 1 paper. Expertise score 0.61. 6 papers in all, 2021–2025.
Topics: All pancreatic cancer, CLDN18.2, KRAS
- Harshabad Singh · Dana-Farber Cancer Institute
In CLDN18.2: 1 paper. Expertise score 0.61. 23 papers, 1 trial, 2 grants in all, 2021–2027.
Topics: All pancreatic cancer, KRAS, CLDN18.2, KRAS G12D
- Hua Jiang
In CLDN18.2: 1 paper. Expertise score 0.61. 2 papers in all, 2017–2023.
Topics: All pancreatic cancer, CLDN18.2
- In-Ho Kim · Catholic University of Korea
In CLDN18.2: 1 paper. Expertise score 0.61. 5 papers in all, 2021–2025.
Topics: All pancreatic cancer, CLDN18.2, KRAS, KRAS G12D
- James M. Cleary · Dana-Farber Cancer Institute
In CLDN18.2: 1 paper. Expertise score 0.61. 26 papers, 3 trials in all, 2014–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2
- Jiping Wang · Brigham and Women's Hospital
In CLDN18.2: 1 paper. Expertise score 0.61. 8 papers in all, 2020–2024.
Topics: All pancreatic cancer, CLDN18.2
- Jonathan Andrew Nowak · Brigham and Women's Hospital
In CLDN18.2: 1 paper. Expertise score 0.61. 41 papers in all, 2017–2026.
Topics: All pancreatic cancer, KRAS, KRAS G12D, CLDN18.2, Early detection
- Joseph Douglas Mancias · Dana-Farber Cancer Institute
In CLDN18.2: 1 paper. Expertise score 0.61. 29 papers, 1 grant in all, 2014–2026.
Topics: All pancreatic cancer, KRAS, KRAS G12D, CLDN18.2
- Junke Wang
In CLDN18.2: 1 paper. Expertise score 0.61. 7 papers in all, 2022–2026.
Topics: All pancreatic cancer, CLDN18.2, KRAS
- Kimberly J. Perez · Dana-Farber Cancer Institute
In CLDN18.2: 1 paper. Expertise score 0.61. 34 papers, 4 trials in all, 2012–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2, Early detection
- Margaret M. Kozak
In CLDN18.2: 1 paper. Expertise score 0.61. 12 papers in all, 2016–2023.
Topics: All pancreatic cancer, KRAS, CLDN18.2, KRAS G12D
- Myung Ah Lee · Catholic University of Korea
In CLDN18.2: 1 paper. Expertise score 0.61. 21 papers, 1 trial in all, 2012–2026.
Topics: All pancreatic cancer, CLDN18.2, KRAS, KRAS G12D
- Nan Niu
In CLDN18.2: 1 paper. Expertise score 0.61. 13 papers in all, 2020–2025.
Topics: All pancreatic cancer, CLDN18.2
- Noelle R. Jurcak
In CLDN18.2: 1 paper. Expertise score 0.61. 5 papers in all, 2019–2024.
Topics: All pancreatic cancer, CLDN18.2
- Pan Li
In CLDN18.2: 1 paper. Expertise score 0.61. 3 papers in all, 2022–2023.
Topics: All pancreatic cancer, CLDN18.2
- Richard Francis Dunne
In CLDN18.2: 1 paper. Expertise score 0.61. 16 papers in all, 2015–2024.
Topics: All pancreatic cancer, KRAS, CLDN18.2, KRAS G12D
- Sara A. Väyrynen
In CLDN18.2: 1 paper. Expertise score 0.61. 8 papers in all, 2019–2023.
Topics: All pancreatic cancer, CLDN18.2, KRAS
- Se Jun Park · Catholic University of Korea
In CLDN18.2: 1 paper. Expertise score 0.61. 8 papers in all, 2019–2026.
Topics: All pancreatic cancer, CLDN18.2, KRAS, KRAS G12D
- Shiyu Liu
In CLDN18.2: 1 paper. Expertise score 0.61. 5 papers in all, 2016–2025.
Topics: All pancreatic cancer, CLDN18.2
- Sophia Y. Chen
In CLDN18.2: 1 paper. Expertise score 0.61. 9 papers in all, 2016–2025.
Topics: All pancreatic cancer, CLDN18.2
- Srivatsan Raghavan · Dana-Farber Cancer Institute
In CLDN18.2: 1 paper. Expertise score 0.61. 18 papers, 1 grant in all, 2018–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2, KRAS G12D
- Tae Ho Hong · Catholic University of Korea
In CLDN18.2: 1 paper. Expertise score 0.61. 21 papers in all, 2012–2026.
Topics: All pancreatic cancer, CLDN18.2, KRAS, KRAS G12D
- Thomas E. Clancy · Brigham and Women's Hospital
In CLDN18.2: 1 paper. Expertise score 0.61. 30 papers in all, 2015–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2, Early detection, KRAS G12D
- Vicente Morales‐Oyarvide
In CLDN18.2: 1 paper. Expertise score 0.61. 24 papers in all, 2016–2023.
Topics: All pancreatic cancer, KRAS, CLDN18.2, KRAS G12D
- William C. Hahn · Dana-Farber Cancer Institute
In CLDN18.2: 1 paper. Expertise score 0.61. 12 papers, 3 grants in all, 2018–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2, KRAS G12D